Filing Details
- Accession Number:
- 0001645113-20-000049
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-03-10 16:20:51
- Reporting Period:
- 2020-03-06
- Accepted Time:
- 2020-03-10 16:20:51
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1645113 | Novocure Ltd | NVCR | Surgical & Medical Instruments & Apparatus (3841) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1744884 | Pritesh Shah | C/O Novocure Inc., 20 Valley Stream Parkway, Suite 300 Malvern PA 19355 | Chief Commercial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Restricted Share Units | Disposition | 2020-03-06 | 2,906 | $69.53 | 86,438 | No | 4 | S | Direct | |
Ordinary Shares | Acquisiton | 2020-03-06 | 17,500 | $7.48 | 103,938 | No | 4 | M | Direct | |
Restricted Share Units | Disposition | 2020-03-06 | 3,245 | $64.27 | 100,693 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Ordinary Shares | Options to Buy Ordinary Shares | Disposition | 2020-03-06 | 17,500 | $7.48 | 17,500 | $7.48 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
14,518 | 2024-02-25 | No | 4 | M | Direct |
Footnotes
- Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units vested on March 5, 2020. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
- Transaction was made pursuant to a Rule 10b-5-1 trading plan adopted by Mr. Shah.
- Fully vested as of the date hereof.